GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Mid-range Performer
2752.0000 -9.70 (-0.35%)
NSE Sep 24, 2025 13:22 PM
Volume: 19,045
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
19 May 2020
2752.00
-0.35%
buy
by Karvy
Target: 1292
Karvy
GlaxoSmithKline Pharmaceuticals Ltd: Outlook & Valuation: We downgrade our revenue estimates for FY21E by 4.3% to Rs 34.5 bn and introduce our revenues for FY22E.
 
Number of FII/FPI investors increased from 340 to 390 in Jun 2025 qtr.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market trades lower, Kaynes Tech appoints Muthukumar Narayanaswamy as the MD for 5 years
Trendlyne Marketwatch | 24 Sep 2025, 01:04PM
Five stocks to buy from analysts this week - September 23, 2025
The Baseline | 23 Sep 2025, 06:11PM
IPO market heats up: 29 new offerings and 8 listings this week
| 22 Sep 2025, 05:34PM